RT Journal Article
T1 Predictive model of pheochromocytoma based on the imaging features of the adrenal tumours.
A1 Araujo-Castro, Marta
A1 García Centeno, Rogelio
A1 Robles Lázaro, Cristina
A1 Parra Ramírez, Paola
A1 Gracia Gimeno, Paola
A1 Rojas-Marcos, Patricia Martín
A1 Fernández-Ladreda, Mariana Tomé
A1 Percovich Hualpa, Juan Carlos
A1 Sampedro Núñez, Miguel
A1 López-García, María-Carmen
A1 Lamas, Cristina
A1 Álvarez Escolá, Cristina
A1 Calatayud Gutiérrez, María
A1 Blanco Carrera, Concepción
A1 de Miguel Novoa, Paz
A1 Valdés Gallego, Nuria
A1 Hanzu, Felicia
A1 Marazuela, Mónica
A1 Mora Porta, Mireia
A1 Mínguez Ojeda, César
A1 García Gómez Muriel, Isabel
A1 Escobar-Morreale, Héctor F
A1 Valderrabano, Pablo
AB The purpose of our study was to develop a predictive model to rule out pheochromocytoma among adrenal tumours, based on unenhanced computed tomography (CT) and/or magnetic resonance imaging (MRI) features. We performed a retrospective multicentre study of 1131 patients presenting with adrenal lesions including 163 subjects with histological confirmation of pheochromocytoma (PHEO), and 968 patients showing no clinical suspicion of pheochromocytoma in whom plasma and/or urinary metanephrines and/or catecholamines were within reference ranges (non-PHEO). We found that tumour size was significantly larger in PHEO than non-PHEO lesions (44.3 ± 33.2 versus 20.6 ± 9.2 mm respectively; P 
YR 2022
FD 2022-02-17
LK http://hdl.handle.net/10668/19589
UL http://hdl.handle.net/10668/19589
LA en
DS RISalud
RD Apr 15, 2025